SPERZEL JOHN J III (See Remarks) exercised options at T2 BIOSYSTEMS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 2/20/2024ACC: 0000950170-24-017071
DirectorOfficer· See Remarks
Since Jan 2020
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
160.00 acquired · 160.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+160.00
Price / share
—
Trade value
—
% of position
92.5%
2/20/2024
173.00→333.00
Total
Net shares
+160.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/20/2024 | M · Option Exercise | +160.00 | — | — | 92.5% | 173.00 | 333.00 |
| Total | +160.00 | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
160.00 shares
Shares
−160.00
Strike price
Held after
160.00
Exercisable
—
2/20/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock160.00 shares | 2/20/2024 | M · Option Exercise | −160.00 | — | 160.00 |